Results 141 to 150 of about 50,322 (265)

Cellular Senescence, Inflammaging and Cardiovascular Disease

open access: yesImmunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Aging is the most important yet unmodifiable risk factor for cardiovascular disease (CVD). As a result, targeting cardiovascular aging has emerged as a promising strategy to promote long‐term cardiovascular health. This review summarizes current knowledge on the effects of aging within the cardiovascular system as well as systemic processes ...
Lukas Zanders   +3 more
wiley   +1 more source

Colchicine for Prevention of Recurrent Stroke-Are we CONVINCED? [PDF]

open access: yesJ Am Heart Assoc
De Marchis GM   +3 more
europepmc   +1 more source

The Immunological Consequences of Clonal Hematopoiesis in Heart Failure

open access: yesImmunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Inflammation is increasingly recognized as a central driver of heart failure (HF), particularly in older adults, yet the underlying immune mechanisms remain diverse and incompletely understood. Clonal hematopoiesis (CH), defined by the expansion of somatically mutated hematopoietic clones, has emerged as a risk factor for the development of ...
Megan A. Evans, Kenneth Walsh
wiley   +1 more source

Anti-inflammatory pharmacotherapy in patients with cardiovascular disease. [PDF]

open access: yesEur Heart J Cardiovasc Pharmacother
Finocchiaro S   +14 more
europepmc   +1 more source

The Effect of Low‐Dose Colchicine on the Phenotype and Function of Neutrophils and Monocytes in Patients with Chronic Coronary Artery Disease: A Double‐Blind Randomized Placebo‐Controlled Cross‐Over Study [PDF]

open access: hybrid
Helin Tercan   +10 more
openalex   +1 more source

Trained Immunity and Cardiovascular Risk: An Immunological Perspective

open access: yesImmunological Reviews, Volume 337, Issue 1, January 2026.
ABSTRACT Systemic inflammation is a key driver of atherogenesis and its complications. While anti‐inflammatory therapies targeting pathways such as IL‐1β and IL‐6 have shown promise in established atherosclerotic cardiovascular disease (ASCVD), potential systemic effects raise concerns about immune suppression and infection, underscoring the need for ...
Katherine A. Boden   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy